Analysis Version
v1
History
Back to Study: Repurposing glucagon-like peptide-1 (GLP-1) recept...
quantitative
Analysis v1
Strong Support

So far, only one in three studies has found that diabetes drugs called GLP-1 agonists might help with depression, so the proof isn't strong or clear yet.

20
Pro
0
Against

Evidence from Studies

Supporting (1)

20

Community contributions welcome

20

Repurposing glucagon-like peptide-1 (GLP-1) receptor agonists for the treatment of depression: A systematic review of preclinical, observational and clinical investigations.

Systematic Review
Human
2025 Oct

The study looked at clinical trials of GLP-1 drugs for depression and found that only one out of three showed real benefits, which matches the claim that evidence is weak and not consistent.

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Source Study

Repurposing glucagon-like peptide-1 (GLP-1) receptor agonists for the treatment of depression: A systematic review of preclinical, observational and clinical investigations.

Score: 20
DOI: 10.1016/j.euroneuro.2025.08.002

Similar Assertions

Some diabetes drugs called GLP-1 agonists might help ease depression in people, based on early studies — but we’re not sure yet because the research has some flaws.

55
0
91%

Some diabetes drugs called GLP-1 agonists might help with depression symptoms, based on a few studies — but the results aren't clear-cut and more research is needed.

20
0
90%

People with type 2 diabetes who take GLP-1 drugs like Ozempic might feel a little better emotionally, but the mood boost is small and doesn’t show up in every study.

20
0
86%

People with type 2 diabetes or obesity who take GLP-1 drugs like semaglutide might be less likely to develop depression or anxiety.

50
0
83%

Taking diabetes drugs called GLP-1 receptor agonists might slightly improve mood in people, whether or not they have diabetes, based on depression score changes in studies.

55
0
79%